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Background: We have earlier reported that follicle stimulating hormone (FSH) modulates ovarian stem cells which
include pluripotent, very small embryonic-like stem cells (VSELs) and their immediate descendants ‘progenitors’
termed ovarian germ stem cells (OGSCs), lodged in adult mammalian ovarian surface epithelium (OSE). FSH may
exert pleiotropic actions through its alternatively spliced receptor isoforms. Four isoforms of FSH receptors (FSHR)
are reported in literature of which FSH-R1 and FSH-R3 have biological activity. Present study was undertaken to
identify FSHR isoforms mediating FSH action on ovarian stem cells, using sheep OSE cells culture as the study
model.
Methods: Cultures of sheep OSE cells (a mix of epithelial cells, VSELs, OGSCs and few contaminating red blood
cells) were established with and without FSH 5IU/ml treatment. Effect of FSH treatment on self-renewal of VSELs
and their differentiation into OGSCs was studied after 15 hrs by qRT-PCR using markers specific for VSELs (Oct-4A,
Sox-2) and OGSCs (Oct-4). FSH receptors and its specific transcripts (R1 and R3) were studied after 3 and 15 hrs of
FSH treatment by immunolocalization, in situ hybridization and qRT-PCR. FSHR and OCT-4 were also immuno-
localized on sheep ovarian sections, in vitro matured follicles and early embryos.
Results: FSH treatment resulted in increased stem cells self-renewal and clonal expansion evident by the
appearance of stem cell clusters. FSH receptors were expressed on ovarian stem cells whereas the epithelial cells
were distinctly negative. An increase in R3 mRNA transcripts was noted after 3 hrs of FSH treatment and was
reduced to basal levels by 15 hrs, whereas R1 transcript expression remained unaffected. Both FSHR and OCT-4
were immuno-localized in nuclei of stem cells, showed nuclear or ooplasmic localization in oocytes of primordial
follicles and in cytoplasm of granulosa cells in growing follicles.
Conclusions: FSH modulates ovarian stem cells via FSH-R3 to undergo potential self-renewal, clonal expansion as
‘cysts’ and differentiation into oocytes. OCT-4 and FSHR proteins (required initially to maintain pluripotent state of
VSELs and for FSH action respectively) gradually shift from nuclei to cytoplasm of developing oocytes and are later
possibly removed by surrounding granulosa cells as the oocyte prepares itself for fertilization.
Keywords: FSH, FSHR, Ovary, Stem cells, OCT-4, VSELsIntroduction
Follicle stimulating hormone (FSH) is a pleiotropic hor-
mone produced by the pituitary that exerts diverse actions
on the gonads like growth, proliferation, differentiation, fa-
cilitates steroidogenesis and also acts as an anti-apoptotic
survival factor in vitro, besides being associated with post-* Correspondence: bhartiyad@nirrh.res.in
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reproduction in any medium, provided the ormenopausal bone loss [1] and is also implicated in various
kind of tumors [2-4]. As per current understanding, FSH
receptors are localized on the granulosa cells in the ovary
and Sertoli cells in the testis, which constitute the somatic
niche and provide physical and biochemical support
(source of growth factors and cytokines) to germ cells dur-
ing their differentiation and development recently reviewed
[5]. However, several published reports using ovarian tissue
or immortalized ovarian epithelial cell lines suggest thatd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the normal ovary surface epithelium (OSE) [6-8], ovarian
tumors [9-15], oocytes and cleavage stage mouse embryos
[16,17]. Evidence is also available that blocking FSH action
results in azoospermia in non-human primates [18] and a
significant loss of primordial follicles in hamster ovaries
[19]. Thus it remains rather ambiguous at present whether
FSH regulates germ cells function indirectly through the
granulosa or Sertoli cells or does FSH exert direct action
on both the somatic and germ cell compartment in the
gonads.
Results from our group suggest that FSH may be
exerting direct action on ovarian stem cells in the ovary,
besides the well-studied action on the granulosa cells. We
have reported that besides the granulosa cells of antral fol-
licles, FSH receptors are also expressed in adult mouse
OSE, which houses the pluripotent very small ES-like stem
cells (VSELs) and ovarian germ stem cells (OGSCs). Treat-
ment with pregnant mare serum gonadotropin (PMSG) ac-
tivates VSELs and OGSCs in the OSE, and results in
augmented neo-oogenesis and primordial follicle assembly
[20]. Stimulatory effect of FSH on the VSELs residing in
the OSE was also demonstrated by us in cortical tissue cul-
ture of human and marmoset ovarian cortical tissue. The
OSE underwent extensive proliferation in response to FSH
treatment and both pluripotent stem cells and germ cells
were increased in number along with certain degree of
transition of primordial follicles [21].
Pioneering work done by Sairam’s group has shown that
FSH may exert multiple effects on the gonads through
alternatively spliced FSH receptors (FSHR) and four differ-
ent alternatively spliced isoforms of FSHR are reported
[22,23]. The canonical FSH-R1 is a 75 kDa member of the
G-protein coupled receptor superfamily, expressed on the
granulosa cells of growing follicles responsible for ste-
roidogenesis via the cAMP signal transduction pathway.
Whereas FSH-R3 is a 39 kDa protein expressed by both
surface epithelial and granulosa cells and has topology of a
growth factor receptor and promotes DNA synthesis lead-
ing to proliferation via mitogen-activated protein kinase
(MAPK) pathway, specifically the extracellular-regulated
kinase (ERK) signaling cascade and voltage-dependent
calcium channels [14,24,25]. R1 and R3 transcripts differ
from each other in the exons 9 to 11; R1 has exons 9 and
10 and lacks exon 11 whereas R3 lacks exons 9 & 10 and
has a putative exon 11 [25,26].
Published literature suggests that R3 transcript is
probably the more pre-dominant transcript in ovaries.
Quantitative RT-PCR studies on sheep granulosa cells
collected from follicles in different development stages
show that R3 transcript is highly regulated and is 20–50
fold more abundant than R1 in small to medium sized
follicles, whereas in pre-ovulatory follicles R3 is 5-fold
more expressed than R1 [27]. Interestingly R3 is alsomore regulated during follicular development after PMSG
treatment compared to R1 in mice [26,28]. Li et al. [14]
have shown that R3 signaling promotes proliferation of
ovarian cancer cells. Differential roles played by the two
transcripts R1 and R3 in various biological processes, can
be easily dissected by a careful designing of primer and
probe sequences [14,26].
It becomes vital, at this juncture to delineate the differen-
tial regulation of R1 and R3 in response to PMSG/FSH
treatment that results in augmented stem cell activity and
primordial follicle assembly in adult mammalian (mouse,
monkey and human) ovary reported recently by our group
[20,21]. Thus the present study was undertaken to examine
the effect of FSH treatment on R1 and R3 receptor isoforms
and stem cell specific markers for VSELs (Oct-4A, Sox-2)
and OGSCs (Oct-4) on sheep OSE cells cultured in vitro.
In addition, immunolocalization studies were carried out
for FSHR and OCT-4 on sheep ovarian sections to study
how OCT-4 (one of the 27 crucial maternally inherited
genes), transitions and is differentially expressed during oo-
genesis (in vitro matured MI and MII oocytes) and early
embryogenesis.
Materials and methods
The study was approved by the Institute Animal Ethics
Committee and sheep ovaries obtained from local abattoir
were transported in 0.9% normal saline containing antibi-
otics (Penicillin 100 U/mL, Streptomycin 100 μg/mL;
Invitrogen, USA) at ambient temperature adjusted to 22 ±
3°C within an hour of slaughter. Few ovaries were fixed in
10% neutral buffered formalin (NBF) at 4°C, some were
immediately frozen for RNA studies and remaining was
used for establishing cultures. Granulosa cells from imma-
ture and mature sheep ovarian follicles (collected and
pooled during routine in vitro maturation of sheep eggs in
the lab as reported earlier [29] as well as immature and
mature oocytes and embryos were also studied for expres-
sion of both FSHR and OCT-4 proteins and their mRNA
transcripts.
Sheep ovary surface epithelial cells (OSE) culture
Ovaries were rinsed gently several times in calcium-and
magnesium-free Dulbecco’s phosphate-buffered saline
(DPBS; Invitrogen) containing antibiotics. Any extraneous
tissue was dissected out carefully without disturbing the
OSE layer. The ovaries were subsequently placed in plain
high-glucose DMEM/F12 (Sigma Aldrich, USA) containing
antibiotics and their surface was gently scraped with the
help of a sterile blunt cell scraper to release the cells as de-
scribed earlier [30]. These cells were spun at 1000 g for 10
mins at room temperature (RT) and finally re-suspended
in DMEM/F12 medium supplemented with 10% fetal bo-
vine serum (FBS) with antibiotics and were cultured in 5%
CO2 incubator at 38.5°C with or without FSH (5 IU/ml,
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and 15 hrs.
Preparation of sheep OSE cell smears
The initial scraped OSE cells and the whole cell suspen-
sion (attached as well as floating) after culture was used
to make smears on poly L-lysine (Sigma Aldrich) coated
slides for H&E and other studies. For in situ hybridization
(ISH) utmost precautions were taken during various steps
to prevent RNA degradation and the slides were rinsed in
0.1% diethyl pyrocarbonate (DEPC, Sigma Aldrich) treated
water to remove any traces of RNases prior to use. Smears
were stored at 4°C till further use.
Immuno-localization studies
Immuno-localization for FSHR and OCT-4 were carried
out on both surface epithelial cell smears and on paraffin
sections of sheep ovaries. For FSHR immunolocalization,
an antipeptide antibody raised in rabbits against 285–309
region of rat FSHR (with no homology with LHR and
TSHR) [31] was used since it showed cross-reactivity with
sheep ovarian tissue. OCT-4 polyclonal antibody (Abcam,
UK) localized differentially to nuclei or cytoplasm of
stem cells depending on whether the stem cells are pluri-
potent (VSELs) or initiated differentiation into progeni-
tors (OGSCs), as reported earlier by our group [30,32].
SSEA-4 is a cell surface marker for pluripotent stem
cells (Millipore, USA) and is expressed by both VSELs
and OGSCs are reported earlier by our group [30].
Briefly the paraffin embedded ovarian sections were de-
paraffinized and incubated with 3% hydrogen peroxide
(Qualigens, India) in methanol for 1 hr and then gradually
hydrated in descending series of methanol. This was
followed by antigen retrieval by immersing the slides in
boiling sodium citrate (SSC) buffer at pH 6 for 5 mins
(FSHR) and 20 mins (OCT-4). After cooling, the slides
were washed with 1X Tris buffered saline (TBS) buffer for
5 mins and then permeabilized (for OCT-4) with 0.3% Tri-
ton X-100 in TBS buffer for 5–7 mins. Then after three
washes with TBS buffer (5 mins each), the slides were
blocked with 10% normal goat serum (NGS) and 1% bovine
serum albumin (BSA) in TBS overnight at 4°C to prevent
non-specific staining. Next day, after removing excess
blocking reagent, the slides were incubated with primary
antibody against FSHR (1 in 200 dilution) and OCT-4 (1 in
50 dilution) for 2 hrs at RT. This was followed by 4–5
washes and then detection was carried out according to
manufacturer’s instructions using anti Rabbit Vecta ABC
kit (Vector Laboratories, USA). Color reaction was per-
formed using diaminobenzidine (Biogenex, USA) and after
obtaining appropriate staining, the slides were dipped in
water and counterstained with Haematoxylin. Slides were
later viewed under bright-field 90i microscope (Nikon,
Japan) and representative fields were photographed.For OSE smears, similar procedure was used as men-
tioned above with the omission of de-paraffinization and
antigen retrieval steps. For immunofluorescence studies,
the OSE smears were hydrated in phosphate buffer saline
(PBS), permeabilized (for OCT-4) with 0.3% Triton X for 5
mins, followed by 2 hrs blocking in 10% NGS and 1% BSA
in PBS. After removing excess blocking, the smears were
incubated overnight with primary antibody against FSH re-
ceptor (1:100), OCT-4 (1:50) and SSEA-4 (1:50) at 4°C.
Next day the slides were brought to RT and then washed
3–4 times with PBS (5 mins each) to remove excess un-
bound antibody. Then the smears were incubated with
anti-rabbit secondary antibody Alexaflour 488 (1:1000)
for 2 hrs at RT. After washes with PBS, the smears
were then counterstained with propidium iodide (PI, Sigma
Aldrich; 5 mg/ml) and mounted using Vectashield and
stored at 4°C till viewing. The slides were scanned under
laser scanning confocal fluorescent microscope (LSM
510-META, ZEISS, Germany) and representative fields
were photographed.RNA extraction and cDNA synthesis
RNA was extracted from scraped OSE cells using TRIZOL
(Invitrogen) reagent by standard protocol followed by
DNase I (Amersham Biosciences, USA) treatment at 37°C
for 30 mins to remove any genomic DNA contamination.
Reverse transcription of cDNA was performed using iScript
cDNA synthesis kit (Bio-Rad, USA) according to the manu-
facturer’s instructions. Briefly, RNA was incubated with 5×
iScript reaction mix and iScript reverse transcriptase mix.
The reaction was carried out in G-STORM thermocycler
(Gene Technologies, UK). The reaction mix was first incu-
bated at 25°C for 5 mins, then at 42°C for 30 mins and
finally at 85°C for 5 mins.Selection of primers for qRT-PCR studies
Primers for FSHR isoforms (Table 1) were taken from an
earlier publication [26] and were basically designed from
exon 10 (FSH receptor transcript R1) and exon 11 (FSH
receptor transcript R3) respectively of the FSHR gene.
Markers specific for pluripotency (Oct-4A and Sox-2)
were selected for studying VSELs. Oct-4A is a marker for
pluripotent state and once the pluripotent stem cell starts
differentiating, nuclear OCT-4 is no longer required and
shifts to the cytoplasm and major associated transcript is
Oct-4B. We have earlier reported that VSELs express
Oct-4A (amplified by Oct-4A primer) and OGSCs (im-
mediate descendants of VSELs) express Oct-4B (ampli-
fied by Oct-4 primer which amplifies all isoforms).
These primers (Table 1) have been used to detect VSELs
and OGSCs [30,32] and have been designed based on
earlier publication [33].
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The expression levels of Fsh-r1, Fsh-r3, VSELs (Oct-4A,
Sox-2) and OGSCs (Oct-4) specific markers and house-
keeping transcript Gapdh were estimated using CFX96
Real-Time PCR system (Bio-Rad Laboratories, USA) using
SYBR Green chemistry (Bio-Rad). The amplification con-
ditions were: initial denaturation at 94°C for 3 mins
followed by 40 cycles comprising of denaturation at 94°C
for 30 seconds, primer annealing at specific temperature
for 30 seconds, and extension at 72°C for 30 seconds. The
final extension was carried out for 5 mins at 72°C. The
fluorescence emitted at each cycle was captured during
the extension step of each cycle. The homogeneity of the
PCR amplicons was verified by running the products on
2% agarose gels. All PCR amplifications were carried out
in duplicate. Mean Ct values generated in each experiment
using the CFX Manager software (Bio-Rad) were used to
calculate the mRNA expression levels. Since delta Ct
is inversely proportional to relative mRNA expression
levels, the values were calculated manually by the delta
Ct method. The relative expression levels of each tran-
script from three different experiments are represented
individually due to considerable variation in the initial
population of cells.
In Situ Hybridization (ISH) on OSE smears
Expression of FSH receptor transcripts were studied using
specific oligo probes by non-radioactive method and all
the reagents were purchased from Roche (Roche Diagnos-























GCC CAG AAC ATC ATC CCT G
GGT CCT CAG TGT AGC CTA G
Oct-4A is a true marker for pluripotent stem cells [33]. Oct-4 primers amplify both Oct-
increase in Oct-4 reflects increase in the number of OGSCs suggesting differentiation.FSH treatment were fixed in paraforma aldehyde in PBS
prepared using DEPC treated water for 20 mins, smears
were prepared on 3-aminopropyltriethoxysilane-coated
glass slides then air dried and stored at 4°C until use. The
probes used for in situ hybridization for R1 was from exon
10 (5’-TCTTT CCCATCTTTG GCATC −3’) and for R3
was from exon 11 (5’-ATATATT CAAAGATAAA
CATACACCAA GAGAA-3’) commercially synthesized
(Sigma) and labeled with Digoxigenin using the 3’ tailing kit
according to the manufacturer’s instructions (Roche). The
specificity of the probe sequence was established by exam-
ining its homology with other sequences in the database.
All database searches were carried out using the BLAST
search engine at www.ncbi.nlm.nih.gov.
For ISH, the smears were hydrated and refixed in 2%
PFA for 10 mins. After washing in 0.1 M PBS (pH 7.0), the
slides were incubated in 2X SSC (1X SSC comprised
0.15 M sodium chloride and 0.015 M sodium citrate,
pH 7) for 15 mins at RT. Pre-hybridization was carried
out at 42°C for 1 hr in a pre-hybridization cocktail
containing 50% formamide, 4X sodium saline citrate
(SSC), 5X Denhardt’s solution, 0.25% yeast tRNA, 0.5%
sheared Salmon sperm DNA, and 10% dextran sulphate.
After pre-hybridization, the smears were hybridized
overnight at 42°C with the labeled probe diluted in the
pre-hybridization mix at a concentration of 5 pmol/μl.
The sections were stringently washed in varying con-
centrations of SSC containing 0.1% Tween 20 (4X SSC,
20 mins twice; 2X SSC, 20 min twice; 1X SSC, 10 min
once) followed by blocking for 2 hrs at RT in blockingy







4A and other isoforms including Oct-4B. Oct-4A reflects VSELs whereas several fold
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Tris–HCl buffer (pH 7.5). After blocking, the sections were
incubated overnight at 4°C in alkaline phosphatase-
conjugated anti-Dig antibody diluted (1:500) in the above
blocking solution. The slides were then extensively washed
in 0.1 M Tris–HCl (pH 7.5) and equilibrated in 0.1 M
Tris–HCl (pH 9.5) for 10 mins. Detection was carried out
at pH 9.5 at RT in a solution of nitro blue tetrazolium
(NBT) and 5-bromo-4-chloro-2-indoyl phosphate (BCIP)
containing 0.2% levamisole and mounted using aquamount.
The sections were viewed and representative fields were
photographed using 90i bright-field microscope (Nikon,
Japan). The smears incubated using a sense probe served as
negative controls.
Results
Studies carried out on sheep ovary surface epithelium
FSH effect on OSE smears
Cells visualized after H & E staining of OSE smears (Figure 1)
included the epithelial cells and putative stem cells inter-
spersed with occasional red blood cells. Epithelial cells
were easily identified by their cuboidal to spindle shape
with oval, pale stained nucleus and abundant cytoplasm,
whereas the putative stem cells were spherical in shape
with a typical dark stained nucleus, minimal cytoplasmFigure 1 Effect of FSH treatment on sheep ovary surface epithelium (
staining. Epithelial cells (spindle shaped cells with pale nuclei and abundant cyto
(arrow) and OGSCs (asterisk) are evident along with red blood cells (RBCs) (B, b)
of FSH treatment. The nests represent rapid stem cells clonal expansion with inc
15 hrs culture without FSH. These observations were made in more than three
after 15 hrs culture (B, b, C, c) appear similar and relatively bigger in size compaand high nucleo-cytoplasmic ratio. The stem cells com-
prised of two distinct populations based on their size. These
included the very small embryonic-like stem cells (VSELs)
and their immediate descendants ‘progenitors’ which were
slightly bigger termed the ovarian germ stem cells (OGSCs)
and small clusters of OGSCs, representing rapid prolifera-
tion with incomplete cytokinesis. Germ cell clusters are also
termed ‘cysts’ or ‘nests’, are well defined structures in fetal
ovaries and their presence in adult ovary is a crucial evi-
dence in support of postnatal oogenesis and primordial fol-
licle assembly. We have described and characterized these
stem cells in our earlier publications [30,34]. The VSELs
were always present singly whereas the OGSCs were ob-
served singly and also as small clusters (Figure 1A). 15 hrs
of FSH treatment induced stem cell proliferation and led to
a marked increase in number of ‘cysts’ reflecting clonal ex-
pansion (Figure 1B). The epithelial cells also appeared big-
ger in size. 15 hrs cultures without FSH treatment showed
altered morphology of the epithelial cells however, the stem
cells did not show clonal expansion (Figure 1C).
FSH effect on ovarian stem cells
The VSELs expressed nuclear OCT-4 (Figure 2A&B)
confirming their pluripotent state whereas the slightly big-
ger OGSCs expressed cytoplasmic OCT-4. The cytoplasmicOSE) smears. (A, a) Freshly prepared sheep OSE smear after H & E
plasm) and distinct populations of putative stem cells including the VSELs
Note the increase in number of stem cells and germ cell ‘cysts’ after 15 hrs
omplete cytokinesis and characteristic of the OGSCs (C, c) OSE smear after
different experiments. Note absence of stem cells activity. Epithelial cells
red to the epithelial cells in fresh OSE (A, a). Scale bar represents 20 μm.
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idly dividing cells in the cell clusters (formed as a result of
clonal expansion of stems cells which undergo rapid divi-
sions and as a result the daughter cells remain connected)
was demonstrated by using a cell surface marker SSEA-4
(Figure 2C).
qRT-PCR analysis of pluripotent stem cell markers (Oct-
4A and Sox-2) and those suggestive of initiation of differen-
tiation of VSELs (Oct-4) into OGSCs revealed that all the
transcripts were up-regulated in response to FSH treatment
by 15 hrs of culture. Increase in Oct-4A and Sox-2 sug-
gested that VSELs were undergoing potential self-renewalFigure 2 Characterization of stem cells in sheep OSE smears. (A) OCT-
Note that only stem cells express OCT-4 whereas the somatic epithelial cel
imaging of ovarian stem cells stained for OCT-4 with PI as the nuclear coun
OGSCs and also the ‘cysts’ express cytoplasmic OCT-4. First column shows
column is the merged image. (C) Confocal image of a cell surface marker S
Z stack imaging of a cell cluster collected after FSH treatment shows cytop
distinct feature of clonal expansion of a stem cell. Magnification 63X with 3
expression of pluripotent VSELs specific (Oct-4A and Sox-2) and OGSCs spe
compared to without FSH (grey bars). Results are representative of three diand increased Oct-4 suggested increased differentiation and
proliferation of OGSCs to form ‘cysts’ (Figure 2D).FSH effect on FSH receptor expression in OSE
After 15 hrs of FSH treatment, FSHR was immunolocalized
in the VSELs, OGSCs and cell clusters whereas the epithe-
lial cells were distinctly negative (Figure 3A). Confocal im-
aging further confirmed the presence of FSHR (Figure 3B)
and OCT-4 in the stem cells (Figure 2B). As evident the
small sized VSELs express nuclear FSHR and OCT-4. The
slightly bigger OGSCs and the germ cell nests expressed4 immunolocalization in OSE smear after 15 hrs of culture with FSH.
ls are devoid of OCT-4. Scale bar represents 20 μm (B) Confocal
terstain. VSELs express nuclear OCT-4 whereas the slightly bigger
OCT-4 staining, middle panel shows PI staining whereas the third
SEA-4 to show cytoplasmic continuity in a germ cell nest or a ‘cyst’.
lasmic continuity between cells due to incomplete cytokinesis and is a
X zoom (D) qRT-PCR results showing increased relative mRNA
cific (Oct-4) transcripts after 15 hrs of FSH treatment (black bars)
fferent experiments.
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respectively.
Since we did not have specific antibodies for the isoforms,
they were studied using specific oligoprobes at the tran-
script level by in situ hybridization as well as by qRT-PCR.
In agreement with immunolocalization data, FSHR tran-
scripts also localized in the stem cells and epithelial cells
were negative (Figure 3C&D). Fifteen hours after FSH treat-
ment, FSH receptor transcript R1 mRNA showed nuclear
localization whereas R3 transcript mRNA was both nuclear
and cytoplasmic compartments suggesting active transla-
tion. The small clusters of stem cells invariably showed
cytoplasmic Fsh-r3. Hybridization with sense probe gave
no staining.
qRT-PCR was carried out on three different biological
experiments (Figure 4). FSH appeared to differentially
regulate R3 transcript compared to R1. As evident, R1
transcript was detected in two of the three samples prior
to culture (4A) and there was not much change in expres-
sion pattern of R1 transcript mRNA after 3 hrs (4B) and
15 hrs (4C) of FSH treatment. The second sample, which
showed no R1 transcript mRNA initially, did express theFigure 3 FSH receptor studies on sheep OSE smears. (A) FSH receptors
whereas the epithelial cells remain distinctly negative. (B) Confocal imaging
whereas the OGSCs have cell surface expression of FSHR. In situ hybridizati
transcripts on FSH treated sheep OSE smears. As evident Fsh-r1 transcript i
Fsh-r3 transcript is localized both in the nuclei and cytoplasm even in the
suggests active involvement of this transcript during FSH action on the stesame after culture. Only one of the three samples expressed
R3 transcript prior to culture (4D) but the levels increased
several times after culture. There was marginal increase in
R3 transcript with and without FSH treatment at 3 hrs in
the first experiment but other two experiments showed 5–
10 times increased expression in untreated group whereas
after 3 hrs of FSH treatment FSH receptor R3 transcript
was 30–40 times more compared to expression pattern
prior to culture (4E). By 15 hrs, R3 similar to R1 transcripts
were expressed at basal levels similar to those observed
prior to culture (4F).
It was not possible for us to combine all the three sam-
ples and represent consolidated data because of variability
in the expression pattern of FSH receptor transcripts prior
to culture. We have no control over sheep ovaries brought
from slaughter house, state of cycle they are in and thus
OSE scrapings may have variable number of stem cells
(which express FSHR). Since we are studying a biological
response and receptor mRNA transcripts, only a minimal
change in expression was expected in response to FSH
treatment (compared to when abundantly expressed tran-
scripts are studied). Thus the results are not evenare immuno-localized on the stem cells and germ cell nests ‘cysts’
of FSHR localization on the stem cells. VSELs show nuclear staining
on results using specific oligo probes for (C) Fsh-r1 and (D) Fsh-r3
s observed in the nuclei of both VSELs (arrow) and OGSCs (asterix).
germ cell nests ‘cysts’. Presence of Fsh-r3 in both cytoplasm and nuclei
m cells.
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treated control.Studies done on sheep ovarian sections
Immuno-localization on sheep ovarian sections (Figure 5)
revealed a similar staining pattern for both FSH-R and
OCT-4. FSHR and OCT-4 staining was observed in the
OSE. The oocytes in the primordial follicles also stained
positive for both FSHR and OCT-4 however, the surround-
ing granulosa cells remained distinctly negative. In primary
to secondary follicles, FSHR and OCT-4 staining was ob-
served in both the oocyte nucleus and the ooplasm whereas
the granulosa cells remained negative. Interestingly in the
mature follicles, both FSHR and OCT-4 were detected in
the cytoplasm of the granulosa cells whereas the surround-
ing thecal layer remained negative. Cytoplasmic FSHR and
OCT-4 in the granulosa cells was confirmed by confocal
microscopy. In certain fields a distinct spatial gradient of
staining pattern was clearly apparent with stronger staining
in the granulosa cells surrounding the antral cavity.Figure 4 Relative mRNA expression (Y-axis) by qRT-PCR for Fsh-r1 an
mRNA expression in (A) initial scraped OSE and after (B) 3 hrs and (C) 15 h
Please note that R1 transcript levels are not affected much by FSH treatme
in (D) initial scraped OSE and after (E) 3 hrs (F) and 15 hrs with (red bars) a
(more than ten-fold) of R3 transcript after FSH treatment at 3 hrs followed
scale to appreciate a difference between D-F). The relative expression level
individually (see Results section for more details).Studies done on sheep granulosa cells, oocytes and
embryos obtained in vitro
Confocal microscopy after immunostaining (Figure 6A)
was carried out on the MI and MII oocytes and surround-
ing granulosa cells. Both (a) FSHR and (b) OCT-4 were ob-
served in the cytoplasm of granulosa cells. (c-f) OCT-4 was
consistently expressed in the oocytes, early stage embryo
and in the blastocyst stage in both the trophoectoderm as
well as in the inner cell mass. qRT-PCR analysis on pooled
granulosa cells collected from the surface of MI and MII
oocytes showed a reduction in relative mRNA expression
for FSH receptor transcripts R1 and R3, Oct-4A and Oct-4
(Figure 6B). R3 mRNA transcript was significantly higher
compared to R1 transcript in MI granulosa cells in agree-
ment with published literature [26-28].
Discussion
Ovarian stem cells including pluripotent, very small
embryonic-like stem cells (VSELs), and slightly larger
‘progenitors’ termed ovarian germ stem cells (OGSCs)
along with small cell clusters termed the ‘cysts’ or ‘nests’d Fsh-r3 transcripts. Upper panel shows R1 transcript of FSH receptor
rs with (dark blue bars) and without (light blue bars) FSH treatment.
nt. Lower panel shows R3 transcript of FSH receptor mRNA expression
nd without (pink bars) FSH treatment. Note the increased expression
by a reduction to basal levels at 15 hrs (please note a change in Y-axis
s of each transcript from three different experiments are represented
Figure 5 Immunolocalization of FSH receptors on sheep ovarian sections (i) FSH receptors. (A) Ovary surface epithelial cells and primordial
follicles showing positive staining for FSHR (B) Primordial follicles (asterix) exhibit positive FSHR staining in the oocyte nucleus as well as in the
ooplasm whereas the surrounding granulosa cells are negative for FSHR (arrow) (C) Secondary follicle showing positive staining for FSHR in
oocyte nucleus and ooplasm and negative for surrounding granulosa cells (D & E) Developing antral follicles show FSHR positive in both
ooplasm and surrounding granulosa cells. (ii) OCT-4 (A & B) certain regions of ovary surface epithelium stain positive for OCT-4. Primordial
follicles exhibit positive OCT-4 staining in the ooplasm (arrow) as well as in the nuclei (asterix) of the oocytes. The secondary follicles show
distinct staining in the ooplasm whereas the surrounding granulosa cells in both primordial and secondary follicles are negative for OCT-4. (C &
D) Large antral follicles have distinct staining for OCT-4 in the granulosa cells whereas the theca cells are negative and note a gradient in the
staining intensity at higher magnification. Scale bar is 20 μm. Images of representative area were photographed using 90i Nikon microscope.
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were easily visualized in scraped sheep ovary surface epi-
thelium (OSE). The present study for the first time dem-
onstrates that the expression of FSH receptors in the OSE
is restricted to the stem cells. FSH interaction through R3
transcript with the stem cells resulted in the potential self-
renewal of VSELs (increased expression of Oct-4A and
Sox-2) and their differentiation into ‘cysts’ comprising
OGSCs (increased expression of Oct-4) representing initial
steps during oogenesis (Figure 7). These results are in
contradiction to the existing paradigm that initial primor-
dial follicle growth is independent of FSH action. Rather
we show that FSH directly acts on the stem cells via FSH-
R3, besides the well-studied action of FSH via canonical
FSH-R1 on the granulosa cells. These results possibly pro-
vide a novel explanation for the significant reduction in
primordial follicle numbers when FSH action was blocked
using polyclonal antibody during perinatal development of
hamster ovaries [19].
The present study also demonstrated an interesting
shift in the staining pattern of FSHR and OCT-4 from
the nuclei of VSELs to the nuclei and/or ooplasm of thedeveloping oocytes in the primordial to primary follicles
(surrounding granulosa cells being distinctly negative)
and in the cytoplasm of the granulosa cells of the growing
follicles along with a gradual loss in the developing oocytes.
The results raise an interesting question whether later
on during development of the follicles, cytoplasmic FSHR
and OCT-4 in the granulosa cells are newly synthesized
proteins with specific functions or are removed from the
developing oocyte (which has minimal machinery of its
own to degrade proteins) as it prepares itself for the next
journey post-fertilization. FSH-R1 is known to be expressed
on the granulosa cells of growing follicles however a reduc-
tion in R1 and R3 and Oct-4 mRNA was noted in the
granulosa cells surrounding the MII oocytes compared to
MI oocytes. We were indeed intrigued as to why two such
un-related proteins show similar staining pattern? OCT-4
(a crucial maternally inherited protein) reappeared in the
nucleus of the developing oocyte. By studying OCT-4 ex-
pression in the ovarian stem cells, developing follicles and
early embryo, we demonstrate how embryogenesis indeed
begins during oogenesis as suggested earlier by [35]. We
have split further discussion into two parts.
Figure 6 Immunolocalization and PCR of FSHR and OCT-4 in the granulosa cells, oocytes and embryo. (A) Confocal microscopy shows
the presence of (a) FSH receptors and (b) OCT-4 in the cytoplasm of the granulosa cells (c-f) OCT-4 localization in MI and MII oocytes and early
embryo. Note the MI oocyte shows both nuclear and cytoplasmic OCT-4 whereas in the MII oocyte OCT-4 was observed in the ooplasm in the
4–8 cells embryo and blastocyst OCT-4 was observed in the blastomeres surrounding trophoectodermal cells as well as in the inner cell mass.
(B) qRT-PCR analysis of FSH receptor transcripts R1 and R3, Oct-4A and total Oct-4 in the granulosa cells surrounding MI and MII oocytes.
R3 transcript mRNA is significantly highly expressed compared to the canonical R1 transcript in the granulosa cells. Note a reduction in all the
transcripts in the granulosa cells collected from MII oocytes. Magnification is 40X and granulosa cells are image at 4X optical zoom. The relative
expression of transcripts is a representation of pooled samples analyzed once.
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stem cell function in vitro
Existence of stem cells in the adult ovary is a debatable
issue and recently Woods and Tilly [36] summarized the
work carried out over the last decade in Professor Tilly’s
lab and equated the ovarian stem cells to the spermato-
gonial stem cells. Whereas Lie and Spradling [37] deny the
presence of stem cells in mouse ovary as they neither
detected rapidly dividing germ stem cells nor ‘cysts’ al-
though adult testis and fetal ovary (positive controls) gave
them the expected staining pattern. Our study provides
support in favor of postnatal oogenesis and also shows the
formation of cysts after FSH treatment in vitro (Figure 1B).
The relatively subtle nature of postnatal oogenesis in adult
mouse ovary compared to fetal ovary and adult testis, may
explain the negative results of Lie and Spradling [37]. We
have earlier reported presence of ‘cysts’ in adult human
ovaries [34]. Results of the present study clearly show that
these ‘cysts’ become prominent after FSH treatment
suggesting that ovarian stem cells are directly modulated
by FSH. Further, the stem cells termed OGSCs by ourgroup are indeed similar to the OSCs reported by Tilly’s
group. However, besides the SSCs in testis and OSCs in
ovary proposed by Tilly’s group [36], we have also reported
the presence of more primitive stem cells termed VSELs
in both testis and ovary [38].
FSH receptors were immuno-localized in the nuclei of
the VSELs (Figure 3A&B) and comprised of both the tran-
scripts FSH-R1 and FSH-R3. This was easily demonstrated
using specific oligo-probes and primers in the nuclei of
the VSELs by in situ hybridization (Figure 3C&D) and
qRT-PCR (Figure 5A-F). An increased expression of Fsh-
r3, from undetectable expression in the initial culture by
qRT-PCR analysis, was noted as early as 3 hrs in FSH
treated group and subtle differences persisted even at
15 hrs compared to untreated control. Stimulatory effect
of FSH on the stem cells via FSH-R3 was clearly evident
on H & E stained OSE smears (Figure 1A&B) and by the
up-regulation of its mRNA transcripts (Figure 4). There
was a dramatic increase in the ‘cysts’ which stained posi-
tive for FSHR (Figure 3A&B) and OCT-4 (Figure 2A&B)
suggesting that the stem cells undergo rapid clonal
Figure 7 Schematic representation of the study results towards better understanding of postnatal oogenesis and follicle assembly.
Small insert represents a model proposed earlier by us [34]. Blue line represents sheep ovarian surface epithelium (OSE). Gentle scraping of OSE shows
the presence of epithelial cells (ECs), red blood cells (RBCs) and stem cells (VSELs, OGSCs and cysts). A crucial pluripotent marker OCT-4 (represented in
brown) shows nuclear expression in VSELs and cytoplasmic in OGSCs and cyst. FSH acts via FSH receptor isoform R3 (rather than the canonical R1
isoform) on the stem cells and regulates self-renewal of VSELs increased (Oct-4A and Sox-2) and clonal expansion of the OGSCs (increased Oct-4) and
formation of cysts (rapid proliferation of OGSCs with incomplete cytokinesis). The OGSCs get surrounded by somatic granulosa cells (formed by
epithelial-mesenchymal transition of OSE cells) resulting in primordial follicle (PF) assembly. PF undergo transition into primary follicle and OCT-4 is
observed in the ooplasm in the developing oocytes whereas the surrounding granulosa cells remain distinctly negative. In pre-antral to antral follicles,
OCT-4 expression gradually decreases in the ooplasm whereas cytoplasmic OCT-4 is observed in the surrounding granulosa cells and interestingly the
staining is relatively dark in cumulus granulosa cells compared to distal granulosa cells (please refer to Figure 5). In vitro matured sheep oocytes show
cytoplasmic OCT-4 staining in surrounding granulosa cells which is reduced in MII compared to MI oocytes. Nuclear OCT-4 reappears in the
developing embryo post-fertilization providing it a pluripotent state. In addition to OCT-4, FSHR which is also required for initial stem cell function
during oogenesis exhibited a similar staining pattern.
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response to the FSH treatment. This was further con-
firmed by increased mRNA expression of pluripotent
markers (Oct-4A and Sox-2) and germ cells specific
marker (Oct-4) by qRT-PCR analysis (Figure 2D). This
early response of FSH- FSH-R3 possibly occurs through
the MAPK pathway and is well documented in literature
[26] however; our data shows for the first time that this
FSH action is restricted to the stem cells located in theOSE. FSH-FSH-R3 interaction on the VSELs resulted in
their proliferation (increased expression of Oct-4A, Sox-2)
and differentiation (increased expression of Oct-4B)
representing initial steps involved in oogenesis. It is an
early effect since Fsh-r3 levels increase within 3 hrs of
FSH treatment whereas Fsh-r1 levels were not altered
(Figure 4). We have earlier reported similar clonal expan-
sion of the stem cells in situ after PMSG treatment in
adult mice ovary [20]. Thus a concomitant up-regulation
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ment supports a potential role of FSH in modulating ovar-
ian stem cells in the present study, in agreement to the
earlier reports [20,21].
If indeed FSH-R3 (which lacks exon 10) is the key player
to mediate FSH action on stem cells resulting in neo-
oogenesis during postnatal life, one could easily explain
why the extensive studies undertaken to search for muta-
tions in the exon 10 of FSH receptor in cases of amenor-
rhea [39] and ovarian tumors [40] have failed to yield any
results. The number of mutations reported so far in FSHR
gene remains low compared to almost 30 reported for LH
receptor [41]. On similar grounds, Oktay et al. [42] failed
to detect FSH receptors on primordial follicles resulting in
the existing paradigm that initial PF growth is gonado-
tropin independent [43]. However, a closer scrutiny of the
primers used for doing RT-PCR by Oktay’s group showed
that they were selected from exon 10 whereas the present
study shows that the primordial follicles express FSH-R3
that lacks exon 10 [25,26]. The standard action of FSH-
FSH-R1 on the granulosa cells via cAMP pathway has
remained the focus of the studies published over decades
in the available literature. But FSH-FSH-R3 interaction
evidently plays a crucial role during neo-oogenesis and
primordial follicle assembly. Sullvian et al. [27] have also
reported that alternatively spliced Fsh-r3 is the pre-
dominant transcript of FSHR in sheep. Babu et al. [26]
have earlier reported a similar two-fold up-regulation of
Fsh-r3 compared to Fsh-r1 after PMSG treatment in mice.
Thus initial lack of knowledge that FSH may exert its
pleiotropic actions through alternatively spliced FSH-R
isoforms has resulted in the existing confusion in the field
of ovarian biology that PF growth is gonadotropin inde-
pendent and needs to be revised.
An association of increased FSH with ovarian cancers,
‘the gonadotropin theory of ovarian tumorigenesis’ exists
[15,44-46]. More than 90% of ovarian cancers arise from
the OSE [47]. The development of ovarian tumors is re-
lated to excessive gonadotropin production associated
with the onset of menopause or premature ovarian fail-
ure [48] and almost 80-90% of them occur with ad-
vanced age [49]. Schiffenbauer and colleagues [50] have
reported that human epithelial ovarian cancers progress
faster in ovariectomized mice due to elevated FSH and
LH levels. Furthermore, Li et al. [14] have earlier shown
that FSH-R3 signaling promotes proliferation of ovarian
cancer cells. We propose that certain yet not well under-
stood changes occur with age in the ovarian microen-
vironment, which are unable to support VSELs/OGSCs
differentiation into oocytes and primordial follicle
assembly in the OSE. This altered interaction of the
stem cells with the microenvironment ‘niche’ results in
menopause. Due to altered cell signaling in certain cases,
the increased FSH levels with advanced age possibly pushthe VSELs via FSH-R3 to undergo uncontrolled prolifera-
tion resulting in cancer [30,34,51]. VSELs are the embry-
onic remnants in adult body tissues that may possibly give
rise to tumors in the body [52]. It is possible that the VSELs
lodged in the OSE result in ovarian cancers by responding
through FSH-R3 to high levels of FSH. Thus a greater un-
derstanding of FSH-FSH-R3 action during neo-oogenesis
from the VSELs lodged in the OSE provided by the present
study and a possible association of these VSELs with ovar-
ian cancers opens up newer avenues for further research.
But if FSH-FSH-R3 interaction with ovarian stem cells
is indeed crucial for neo-oogenesis and PF assembly in
postnatal ovary, FSHRKO mice ovaries should have been
devoid of follicles altogether. However, the small follicles
up to pre-antral stage exist. Also the FSHRKO mice ex-
hibit increased incidence of ovarian tumors in complete
absence of ovulation. These mutants show various tumor
cell types including those related to ovarian surface epi-
thelium around 12–15 months of age [53]. At this junc-
ture it is quite intriguing to find out whether certain
compensatory mechanisms or altered cell signaling path-
ways may result in PF assembly and increased cancer inci-
dence in these animals. However, a well-defined block in
further maturation of the PF is undisputable and exists in
the FSHRKO mice. Balla et al. [54] have reported a signifi-
cant reduction in primordial follicle numbers in 2 day old
ovaries of FORKO mice, suggesting a direct and important
role of FSH-FSHR interaction during ovarian development.
Ghadami et al. [55] reported that Fshr mRNA is readily
expressed in the ovaries of FSHRKO mice after bone mar-
row transplantation. Similarly testosterone secretion has
been reported in LHRKO mice [56] on transplanting tes-
ticular side population cells into the interstitial spaces.
Thus FSHR biology in FSHRKO mice with stem cells per-
spective warrants further investigation. Similarly streak go-
nads are reported in women who are homozygous to an
inactivating mutation of the FSHR [57] and those with an
aberrant FSH beta gene that causes premature protein sub-
unit termination [58]. Aittomaki’s group studied cAMP
levels and concluded that the mutation resulted in de-
creased FSHR activity that may have led to ovarian failure.
However, FSH-FSH-R3 action via MAPK pathway remains
poorly studied in these reports.
Our results are in agreement with recent review [59] that
Gs/cAMP/PKA pathways may not be the sole mechanism
for FSH action (existing paradigm for more than several de-
cades). We conclude that FSH acts through transcript vari-
ants by alternate splicing resulting in protein diversity to
overcome limited number of genes in the genome and to
perform multiple biological functions.
FSHR and OCT-4 immunolocalization on sheep ovaries
Immunolocalization studies on OSE smears show that
both FSHR and OCT-4 have nuclear expression in the
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As the stem cells differentiate into oocytes, OCT-4 expres-
sion shifts to the cytoplasm i.e. ooplasm of oocytes whereas
surrounding granulosa cells were distinctly negative. More
mature follicles show positive cytoplasmic staining in the
granulosa cells and more intense in the cells in close associ-
ation with the developing oocyte. Based on the results we
propose that both OCT-4 and FSHR gradually shift
from the developing oocyte to the granulosa cells as the
follicles mature. As the oocytes mature from MI to MII
stage, a dramatic reduction of total Oct-4 and R1 and
R3 mRNA transcripts is observed in the surrounding
granulosa cells Figure 7.
During intraovarian growth, the oocyte diameter in-
creases 8–10 times with a simultaneous increase in 500
fold increase in volume and fully grown oocyte is the lar-
gest cell in the body with minimal cytoplasmic organelles
including mitochondria, Golgi and endoplasmic reticulum
[60] and lacks lysosomes. It outsources many of its func-
tions to the surrounding cumulus cells [61] while prepar-
ing itself for early embryonic development. Degradation of
oocyte proteins is an essential component of egg-to-em-
bryo transition so that the oogenic program gets erased
and makes way for somatic development [62,63]. Several
transcripts crucial for early embryonic development accu-
mulate whereas a large number of maternal RNA and pro-
teins get degraded during meiotic maturation of the
oocyte. Thus it is likely that proteins like FSH and OCT-4
(in the present study) which were required during early
oogenesis shift from the nuclei of the oocyte to the
ooplasm and then to the granulosa cells possibly through
the transzonal projections (granulosa cell extensions that
traverse the zona pellucida onto the oocyte cell surface)
[64,65] and also explains why we observe a gradient in
staining pattern (Figure 5).Conclusions
Several important insights into FSH role in modulating
ovarian stem cells activity through FSH-R3 resulting in
primordial follicle assembly in the adult mammalian ovar-
ies may be garnered from the present study. Various pro-
teins which play an important role during early oogenesis
are eventually removed from the developing oocyte by the
surrounding granulosa cells through the transzonal pro-
jections. Maternally inherited protein e.g. OCT-4 exhibited
nuclear expression in the VSELs and once they initiate dif-
ferentiation, OCT-4 protein was detected in the cytoplasm
of the developing oocyte and later in the cytoplasm of the
granulosa cells. Once the oocyte matured from MI to MII
state, OCT-4 possibly is de novo synthesized in the oocyte
and persists in the early embryo giving it a pluripotent sta-
tus. More studies need to be undertaken to substantiate
this hypothesis.Present study opens up several directions for further re-
search. Better understanding of postnatal oogenesis and
follicular assembly may lead to better management of
ovarian pathologies, cancer and infertility. Suppressing
FSH-R3 may also provide a newer alternative for fertility
control and the putative exon 11 of FSH should also be
screened for mutations in cases of ovarian pathologies in-
cluding pre-mature ovarian failure and ovarian cancers. It
also reveals an interesting link between OSE, stem cells
and FSH. This may help explain why majority of ovarian
cancers arise in OSE (from stem cells) and also provide an
explanation for gonadotropin theory of ovarian cancers.
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